| Product Code: ETC5821366 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Biologics Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Biologics Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Biologics Market - Industry Life Cycle |
3.4 Sweden Biologics Market - Porter's Five Forces |
3.5 Sweden Biologics Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.6 Sweden Biologics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Sweden Biologics Market Revenues & Volume Share, By Disease? Category, 2021 & 2031F |
3.8 Sweden Biologics Market Revenues & Volume Share, By Biologics Manufacturing, 2021 & 2031F |
4 Sweden Biologics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring biologics treatment |
4.2.2 Growing investment in research and development of biologics |
4.2.3 Favorable government regulations supporting biologics market growth |
4.3 Market Restraints |
4.3.1 High cost associated with biologics development and production |
4.3.2 Stringent regulatory approval process for biologics |
4.3.3 Limited reimbursement policies for biologics treatments |
5 Sweden Biologics Market Trends |
6 Sweden Biologics Market Segmentations |
6.1 Sweden Biologics Market, By Source |
6.1.1 Overview and Analysis |
6.1.2 Sweden Biologics Market Revenues & Volume, By Microbial, 2021-2031F |
6.1.3 Sweden Biologics Market Revenues & Volume, By Mammalian, 2021-2031F |
6.1.4 Sweden Biologics Market Revenues & Volume, By Others, 2021-2031F |
6.2 Sweden Biologics Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Sweden Biologics Market Revenues & Volume, By Monoclonal Antibodies, 2021-2031F |
6.2.3 Sweden Biologics Market Revenues & Volume, By Vaccines, 2021-2031F |
6.2.4 Sweden Biologics Market Revenues & Volume, By Recombinant Proteins, 2021-2031F |
6.2.5 Sweden Biologics Market Revenues & Volume, By Antisense, RNAi, & Molecular Therapy, 2021-2031F |
6.2.6 Sweden Biologics Market Revenues & Volume, By Others, 2021-2031F |
6.3 Sweden Biologics Market, By Disease? Category |
6.3.1 Overview and Analysis |
6.3.2 Sweden Biologics Market Revenues & Volume, By Oncology, 2021-2031F |
6.3.3 Sweden Biologics Market Revenues & Volume, By Infectious Diseases, 2021-2031F |
6.3.4 Sweden Biologics Market Revenues & Volume, By Immunological Disorders, 2021-2031F |
6.3.5 Sweden Biologics Market Revenues & Volume, By Cardiovascular Disorders, 2021-2031F |
6.3.6 Sweden Biologics Market Revenues & Volume, By Hematological Disorders, 2021-2031F |
6.3.7 Sweden Biologics Market Revenues & Volume, By Others, 2021-2031F |
6.4 Sweden Biologics Market, By Biologics Manufacturing |
6.4.1 Overview and Analysis |
6.4.2 Sweden Biologics Market Revenues & Volume, By Outsourced, 2021-2031F |
6.4.3 Sweden Biologics Market Revenues & Volume, By In-house, 2021-2031F |
7 Sweden Biologics Market Import-Export Trade Statistics |
7.1 Sweden Biologics Market Export to Major Countries |
7.2 Sweden Biologics Market Imports from Major Countries |
8 Sweden Biologics Market Key Performance Indicators |
8.1 Number of clinical trials for biologics in Sweden |
8.2 Adoption rate of biologics in different therapeutic areas |
8.3 Investment in biologics research and development in Sweden |
9 Sweden Biologics Market - Opportunity Assessment |
9.1 Sweden Biologics Market Opportunity Assessment, By Source, 2021 & 2031F |
9.2 Sweden Biologics Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Sweden Biologics Market Opportunity Assessment, By Disease? Category, 2021 & 2031F |
9.4 Sweden Biologics Market Opportunity Assessment, By Biologics Manufacturing, 2021 & 2031F |
10 Sweden Biologics Market - Competitive Landscape |
10.1 Sweden Biologics Market Revenue Share, By Companies, 2024 |
10.2 Sweden Biologics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here